Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

VViridian Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
V

Viridian Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $284K. Net result −$127.12M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $284K. Running result $284K. Collaboration: $51K. License: $233K.
  • Cost of revenue: $0. Running result $284K.
  • Gross profit: $284K. Running result $284K.
  • Research and development: −$71.58M. Running result −$71.29M.
  • Selling, general and administrative: −$54.98M. Running result −$126.27M.
  • Other operating benefit: $156K. Running result −$126.11M.
  • Operating income: −$126.27M. Running result −$126.27M.
  • Other expense: −$851K. Running result −$127.12M.
  • Pre-tax loss: −$127.12M. Running result −$127.12M.
  • Income tax benefit: $0. Running result −$127.12M.
  • Net loss: −$127.12M. Running result −$127.12M.